CAS 2101700-15-4

5-amino-3-[4-[[(5-fluoro-2-methoxybenzoyl)amino]methyl]phenyl]-1-[(1S)-2,2,2-trifluoro-1-methylethyl]-1H-Pyrazole-4-carboxamide

CAS: 2101700-15-4

Formula: C₂₂H₂₁F₄N₅O₃

Purity: 97%

Color and Shape: Solid

Molecular weight: 479.4275

Ref: IN-DA01MVY5

(S)-5-Amino-3-(4-((5-Fluoro-2-Methoxybenzamido)Methyl)Phenyl)-1-(1,1,1-Trifluoropropan-2-Yl)-1H-Pyrazole-4-Carboxamide

CAS: 2101700-15-4

(S)-5-Amino-3-(4-((5-Fluoro-2-Methoxybenzamido)Methyl)Phenyl)-1-(1,1,1-Trifluoropropan-2-Yl)-1H-Pyrazole-4-Carboxamide

Purity: 97%

Molecular weight: 479.43g/mol

Ref: 54-PC108688

Pirtobrutinib

CAS: 2101700-15-4

Pirtobrutinib

Purity: ≥98%

Molecular weight: 479.43g/mol

Ref: 54-BUP02511

Pirtobrutinib

CAS: 2101700-15-4

Formula: C₂₂H₂₁F₄N₅O₃

Molecular weight: 479.44

Ref: 4Z-P-422001

LOXO-305

CAS: 2101700-15-4

LOXO-305 is a small molecule inhibitor, which is a synthesized chemical compound designed to selectively target specific enzymes or pathways. Its source is rooted in medicinal chemistry and pharmacological research aimed at elucidating pathways involved in oncogenesis.

Formula: C₂₂H₂₁F₄N₅O₃

Purity: Min. 95%

Color and Shape: Powder

Molecular weight: 479.43 g/mol

Ref: 3D-BL180882

Pirtobrutinib

CAS: 2101700-15-4

Purity: 97%

Molecular weight: 479.16

Ref: 10-F567219

Pirtobrutinib

CAS: 2101700-15-4

Formula: C₂₂H₂₁F₄N₅O₃

Molecular weight: 479.44

Ref: ST-EA-CP-P404004

Pirtobrutinib

CAS: 2101700-15-4

Pirtobrutinib: a selective, non-covalent BTK inhibitor effective against BTK C481 mutations, causing tumor regression in lymphoma models.

Formula: C₂₂H₂₁F₄N₅O₃

Purity: 99.76% - 99.94%

Color and Shape: Solid

Molecular weight: 479.43

Ref: TM-T36287